Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women

Rebecca Rogers, Gloria Bachmann, Zhanna Jumadilova, Franklin Sun, Jon D. Morrow, Zhonghong Guan, Tamara Bavendam

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Abstract

We evaluated overactive bladder (OAB) symptoms and sexual and emotional health in sexually active women with OAB/urgency urinary incontinence (UUI) treated with tolterodine extended release (ER). Sexually active women with OAB symptoms were randomized to placebo or tolterodine ER. Five-day bladder diaries, Sexual Quality of Life Questionnaire - Female (SQOL-F), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ), and Hospital Anxiety and Depression Scale (HAD) were completed at baseline and week 12. Tolterodine ER (n = 201; mean ± SD age, 49 ± 12 years) reduced UUI episodes (P = 0.0029), total (P = 0.0006) and OAB (P < 0.0001) micturitions, and pad use per 24 h (P = 0.0024), and was associated with improvements in SQOL-F (P = 0.004), PISQ total (P = 0.009), and HAD Anxiety (P = 0.03) scores versus placebo (n = 210; mean ± SD age, 47 ± 12 years). OAB symptoms improved with tolterodine ER as did the scores of sexual health and anxiety measures in sexually active women with OAB.

Original languageEnglish (US)
Pages (from-to)1551-1557
Number of pages7
JournalInternational Urogynecology Journal
Volume19
Issue number11
DOIs
StatePublished - 2008

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology
  • Urology

Keywords

  • Anxiety
  • Overactive bladder
  • Sexual health
  • Urgency urinary incontinence
  • Women

Fingerprint

Dive into the research topics of 'Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women'. Together they form a unique fingerprint.

Cite this